Curanex Pharmaceuticals shares rise 11.92% intraday after completing IPO with full exercise of over-allotment option, raising $17.25 million.

Curanex Pharmaceuticals (NASDAQ:CURX) surged 11.92% intraday following the announcement of its successful initial public offering (IPO) and related capital-raising activities. The company closed its IPO on August 27, 2025, raising $15 million at $4 per share, and subsequently exercised the over-allotment option by underwriters, securing an additional $2.25 million. These developments, reported across multiple trusted news outlets including GlobeNewswire and QuiverQuant, signaled strong investor demand and financial flexibility, bolstering market confidence. The intraday price jump aligns with the positive implications of the IPO completion and expanded funding, which positions Curanex to advance its pharmaceutical initiatives.